WCLC 2022 Conference Coverage
I

Lecture Summary - WCLC 2022 Phase II Study of ctDNA Directed Consolidation Durvalumab After Induction and Concurrent Durvalumab With SABR for Stage I NSCLC

By WCLC 2022 Conference Coverage FEATURING Islam Mohamed
By WCLC 2022 Conference Coverage FEATURING Islam Mohamed
35 views
August 23, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Related Content

AUTOPLAY
17:20

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Total Health

J. Porter

1.2K views
36:14

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

798 views
18:47

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Total Health

W. Iams

6.4K views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.1K views
11:07

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical Implicat…

Insights from 2023 ASCO® Annual Meeting

J. West

2.2K views
17:34

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

ecancer

L. Raez

907 views
19:33

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

ecancer

E. Felip, A. Spira, A. Passaro, A. Addeo

491 views
13:19

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

E. Rodriguez

2.1K views
09:37

Controversies in NSCLC: Neoadjuvant vs. Adjuvant IO in Early Stage D…

Luis Raez

399 views
09:40

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

John Conibear

1.8K views
07:31

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Clinical Imp…

Insights from 2023 ASCO® Annual Meeting

J. West

963 views
22:27

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

527 views
14:17

New

WCLC 2024 Insights: Adjuvant vs. Neoadjuvant vs. Peri-Operative Ther…

Insights from 2024 WCLC

J. Von Der Thusen

153 views
08:18

ADC in Combination With Immunotherapy for NSCLC

MI&T Congressi

S. Liu

210 views
22:08

How the Experts Treat: Early Stage NSCLC With Curative Intent

Integrity CE

S. Liu

140 views
20:27

Progress in the Treatment of NSCLC

Yale Cancer Center

R. Herbst

508 views
14:22

Management of mNSCLC Without Actionable Mutations

Integrity CE

M. Baumgart, S. Liu

112 views
11:40

New Immune Checkpoint Inhibitors in Lung Cancer

MI&T Congressi

S. Peters

192 views
10:00

WCLC 2024 Summary: Comparing Treatment for Locally Advanced NSCLC - …

Insights from 2024 WCLC

J. Donington

140 views
26:42

ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 ASCO® …

Total Health

J. Bauman

392 views